NCT03124368
- Conditions
- C3 Glomerulonephritis, C3 Glomerulopathy, Dense Deposit Disease, +12 more
- Locations
-
- Clinical Trial Site Melbourne, Australia
- Clinical Trial Site Antwerp, Belgium
- Clinical Trial Site Leiden, Netherlands
Clinical trial condition
Explore clinical trials studying Membranoproliferative Glomerulonephritis Types I, II, and III. Study availability and eligibility vary by location and protocol.
NCT03124368